ENTITY

Translate Bio Inc (TBIO US)

Analysis

Health Care • United States

Translate Bio, Inc. operates as a therapeutics company. The Company develops transformative medicines for the treatment of diseases caused by protein and gene dysfunction. Translate Bio serves patients in the State of Massachusetts.

Refresh

Focused

No publications yet

There aren’t any podcasts right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00